Search

Search Results
Results 7581 - 7590 of 8337 for Skin Cancer
  • Nexium Intravenous
    Drug - 7 Jan 2025
    Consumer Medicine Information (CMI) about Nexium Intravenous intended for persons living in Australia.
  • Types of Pathology
    Health - 20 Dec 2024
    Pathology plays a critical role in healthcare, linking scientific research to clinical practice and improving disease diagnosis and treatment strategies.
  • Moxicam Capsules
    Drug - 17 Dec 2024
    Consumer Medicine Information (CMI) about Moxicam Capsules intended for persons living in Australia.
  • Cilatil
    Drug - 17 Dec 2024
    Consumer Medicine Information (CMI) about Cilatil intended for persons living in Australia.
  • Understanding Pityriasis Rosea: Treatment and Care
    Health - 16 Dec 2024
    Pityriasis rosea is a common skin condition with red, scaly lesions. Treatment focuses on symptom relief with emollients, corticosteroids, and antihistamines.
  • Evotaz
    Drug - 12 Dec 2024
    Consumer Medicine Information (CMI) about Evotaz intended for persons living in Australia.
  • Vitamin Malabsorption: A Comprehensive Guide from A to K
    Health - 6 Dec 2024
    Malabsorption disrupts vitamin absorption, leading to deficiencies in essential nutrients like A, D, E, K, C, and B12, with significant health implications.
  • Vedafil
    Drug - 3 Dec 2024
    Consumer Medicine Information (CMI) about Vedafil intended for persons living in Australia.
  • Lasix and Lasix High Dose
    Drug - 26 Nov 2024
    Consumer Medicine Information (CMI) about Lasix and Lasix High Dose intended for persons living in Australia.
  • Postrelle-1
    Drug - 25 Nov 2024
    Consumer Medicine Information (CMI) about Postrelle-1 intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback